Sirolimus-Based Immunosuppression in Kidney Transplantation for Type 2 Diabetic Nephropathy

Publisher： Karger

E-ISSN： 1423-0399|84|3|301-304

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.84, Iss.3, 2010-04, pp. : 301-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating sirolimus‐based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 9, 2015-09 ,pp. : 723-723

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of sirolimus‐based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 6, 2015-06 ,pp. : 555-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Withdrawal of tacrolimus stabilizes TGF‐β

By  

NEPHROLOGY, Vol. 20, Iss. 3, 2015-03 ,pp. : 168-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gender‐ and disease‐specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy

By  

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 368-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Prospective Randomised Paired Trial of Sirolimus versus Tacrolimus as Primary Immunosuppression following Non-Heart Beating Donor Kidney Transplantation

By  

Current Urology, Vol. 7, Iss. 4, 2014-08 ,pp. : 174-180

Karger

Access to resources Recommend Favorite